Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MabVax Therapeutics Holdings Inc.

www.mabvax.com

Latest From MabVax Therapeutics Holdings Inc.

Finance Watch: Lilly Cuts 3,500 Jobs Globally To Drive Growth

Lilly will save $500m annually starting in 2018 after $1.2bn in layoff-related costs to reinvest in new products. Also, Cytori halves its headcount; VC OrbiMed closed a $551m Asia fund; and Insmed capitalizes on positive data.

Financing Business Strategies

Deals Shaping the Medical Industry, September 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2016.

Deals BioPharmaceutical

FDA Investigates Lead-Containing Supplement: Health And Wellness Industry Roundup

Deaths potentially linked to Chicago firm's supplements; Vitamin Shoppe in Costa Rica; another own-labeler has GMP problems; and funding boost for protein water firm.

United States Dietary Supplements

Deals Shaping The Medical Industry, May 2015

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, Research/Analytical, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced April 2015.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Inflammation
  • Alias(es)
  • Terrapin Diagnostics Inc.
  • Telik Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • MabVax Therapeutics Holdings Inc.
  • Senior Management
  • J. David Hansen, Pres. & CEO
    Gregory P Hanson, CFO
    Philip Livingston, MD, CSO
    Paul Resnick, MD, VP, CBO
  • Contact Info
  • MabVax Therapeutics Holdings Inc.
    Phone: (858) 259-9405
    11535 Sorrento Valley Rd.
    Ste. 400
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register